RxDoctor Payments Data

Katherine Wehlage, MD

Dermatology · Englewood, CONPI 1760988604

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.

$9,295in general payments, 2019–2025

Across 410 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$865
  • Galderma Laboratories, L.p.$676
  • Sanofi$623
  • LEO Pharma Inc.$622
  • Incyte Corporation$502
  • plus $4K from 26 others

What the payments were for

  • Food & beverage$9,19599%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,295 in reported general payments places this provider in the 85th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$251,469
Medicare patients
814
Services billed
5,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab12$87,129
Dupixent PenDupilumab13$53,557
Clobetasol Propionate77$4,330
Tacrolimus15$3,010
Ketoconazole158$2,603
Fluorouracil31$2,418
Calcipotriene12$1,358
Triamcinolone Acetonide90$966
Doxycycline Hyclate26$919
Desonide20$895
Fluocinonide20$780
Metronidazole15$764
Clindamycin Phosphate18$719
Ciclopirox20$713
ValacyclovirValacyclovir Hcl13$412

Paid to pharmacies, not to this prescriber.

Other dermatology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →